Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Supernus Pharmaceuticals Inc (SUPN)  
$34.11 0.37 (1.1%) as of 4:30 Thu 3/28


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 58,625,000
Market Cap: 2.00(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $22.72 - $38.73
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 106,505 119,208 124,343 450,780
Total Sell Value $3,569,126 $3,929,526 $4,091,741 $15,155,681
Total People Sold 2 5 5 6
Total Sell Transactions 7 10 11 37
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 345
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-21 4 AS $35.31 $511,677 D/D (14,491) 8,570     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-21 4 OE $25.30 $366,622 D/D 14,491 23,061     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-20 4 AS $35.31 $14,124 D/D (400) 8,570 -1%     
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-20 4 OE $25.30 $10,120 D/D 400 8,970     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-19 4 AS $35.31 $436,573 D/D (12,364) 8,570 -2%     
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-19 4 OE $25.30 $312,809 D/D 12,364 20,934     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-13 4 AS $33.48 $2,104,289 D/D (62,366) 8,570 -0%     
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-13 4 OE $12.98 $1,098,523 D/D 62,366 44,686     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-12 4 AS $32.99 $128,133 D/D (3,884) 8,570 5%     
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-03-12 4 OE $12.98 $50,414 D/D 3,884 12,454     -
   Khattar Jack A. President, CEO   •       •      –    2024-02-28 4 D $27.94 $469,057 D/D (16,788) 915,217     -
   Khattar Jack A. President, CEO   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 35,000 932,005     -
   Mottola Frank SVP, Quality, GMP, Ops, IT   •       –      –    2024-02-28 4 D $27.94 $12,852 D/D (460) 7,779     -
   Mottola Frank SVP, Quality, GMP, Ops, IT   •       –      –    2024-02-28 4 OE $0.00 $0 D/D 990 8,239     -
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-02-26 4 AS $30.21 $151,050 D/D (5,000) 8,570 17%     
   Bhatt Padmanabh P. Sr. VP of IP, CSO   •       –      –    2024-02-26 4 OE $9.13 $45,650 D/D 5,000 13,570     -
   Martin Tami Tillotson Sr. V.P., Regulatory Affairs   •       –      –    2024-02-23 4 D $29.06 $14,094 D/D (485) 86,933     -
   Martin Tami Tillotson Sr. V.P., Regulatory Affairs   •       –      –    2024-02-23 4 A $0.00 $0 D/D 1,250 87,418     -
   Mottola Frank SVP, Quality, GMP, Ops, IT   •       –      –    2024-02-23 4 D $29.06 $27,229 D/D (937) 7,249     -
   Mottola Frank SVP, Quality, GMP, Ops, IT   •       –      –    2024-02-23 4 A $0.00 $0 D/D 1,875 8,186     -
   Dec Timothy C Senior Vice-President & CFO   •       –      –    2024-02-23 4 D $29.06 $38,185 D/D (1,314) 7,190     -
   Dec Timothy C Senior Vice-President & CFO   •       –      –    2024-02-23 4 A $0.00 $0 D/D 2,500 8,504     -
   Siebert John M Director   –       •      –    2024-02-23 4 A $0.00 $0 D/D 3,886 87,943     -
   Rubin Jonathan SVP, Chief Medical Officer   •       –      –    2024-02-23 4 D $29.06 $16,477 D/D (567) 4,641     -
   Rubin Jonathan SVP, Chief Medical Officer   •       –      –    2024-02-23 4 A $0.00 $0 D/D 1,250 5,208     -

  345 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed